2021
DOI: 10.1016/j.ecoenv.2020.111838
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic characteristics and identification of PM2.5-induced differentially expressed proteins in hepatocytes and c-Myc silenced hepatocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 40 publications
4
2
0
Order By: Relevance
“…Thus, in p53 +/+ Eμ-Myc male pre-tumoral splenocytes, an increased Ackr4 expression might delay lymphomagenesis in part by attenuating Myc signalling. Indeed, the observed lower expression of Mt2, known to be regulated by Myc (Qin et al, 2021 ), appears consistent with this hypothesis. Importantly, Ackr4 was previously found to inhibit the growth and metastasis of breast, cervical, colorectal, hepatocellular and nasopharyngeal cancer cells (Feng et al, 2009 ;Hou et al, 2013 ;Ju et al, 2019 ;Shi et al, 2015 ;Zhu et al, 2014 ), although no report mentioned any sex-specific bias for cancers occurring in both sexes.…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…Thus, in p53 +/+ Eμ-Myc male pre-tumoral splenocytes, an increased Ackr4 expression might delay lymphomagenesis in part by attenuating Myc signalling. Indeed, the observed lower expression of Mt2, known to be regulated by Myc (Qin et al, 2021 ), appears consistent with this hypothesis. Importantly, Ackr4 was previously found to inhibit the growth and metastasis of breast, cervical, colorectal, hepatocellular and nasopharyngeal cancer cells (Feng et al, 2009 ;Hou et al, 2013 ;Ju et al, 2019 ;Shi et al, 2015 ;Zhu et al, 2014 ), although no report mentioned any sex-specific bias for cancers occurring in both sexes.…”
Section: Discussionsupporting
confidence: 83%
“…However, ChIP-Atlas reported no binding of these proteins at the Mt2 promoter. Alternatively, evidence that Myc may impact on Mt2 expression was obtained previously (Qin et al, 2021 ), and ChIP-Atlas reported Myc binding at the Mt2 promoter in primary B-cells from lymph nodes of Eμ-Myc mice as well as Eμ-Mycinduced lymphoma cells (Figure S3D). This may suggest that the lower expression of Mt2 in pretumoral splenic cells from p53 +/+ Eμ-Myc males (Figure 3E ) might result from a subtle difference in Myc signalling.…”
Section: Transcriptomes From P53 +/+ Eμ-myc and P53 δAs/δas Eμ-myc Ma...mentioning
confidence: 56%
“…Thus, in p53 +/+ Eμ-Myc male pre-tumoral splenocytes, an increased Ackr4 expression might delay lymphomagenesis in part by attenuating Myc signalling. Indeed, the observed lower expression of Mt2, known to be regulated by Myc (Qin et al, 2021), appears consistent with this hypothesis. Importantly, Ackr4 was previously found to inhibit the growth and metastasis of breast, cervical, colorectal, hepatocellular and nasopharyngeal cancer cells (Feng et al, 2009;Hou et al, 2013;Ju et al, 2019;Shi et al, 2015;Zhu et al, 2014), although no report mentioned any sex-specific bias for cancers occurring in both sexes.…”
Section: Discussionsupporting
confidence: 83%
“…As mentioned before, the ACKR4-mediated sequestration of CCL21 may impair the CCR7 signalling cascade, which might lead to decreased MYC activity (Shi et al, 2015). In p53 +/+ Eμ-Myc male splenic cells, the observed lower expression of Mt2, known to be regulated by Myc (Qin et al, 2021), and of many genes that are hallmark Myc targets (as revealed by GSEA), appear consistent with this hypothesis. In addition, Ccr7 is required for lymphoma cell lodging to secondary lymphoid organs (Rehm et al, 2011) and ACKR4 expression was inversely correlated with the metastasis capacity of different types of cancer cells (Shi et al, 2015;Zhu et al, 2014).…”
Section: Discussionsupporting
confidence: 81%
“…Previously, current smokers have shown hypermethylation of cg23771366 [17], located in the serine protease 23 (PRSS23) gene, which encodes a conserved member of the trypsin family of serine proteases [18]. Abnormal regulation of serine protease activity could lead to pathological conditions such as cancer [19]; in vitro assays have also proposed PRSS23 as a potential biomarker of exposure to PM2.5 and reaffirmed its contribution to cancer development [18].…”
Section: Introductionmentioning
confidence: 99%